Cargando…

Lrpap1 (RAP) Inhibits Proximal Tubule Clathrin Mediated and Clathrin Independent Endocytosis, Ameliorating Renal Aminoglycoside Nephrotoxicity

KEY POINTS: Proximal tubule endocytosis of toxins often leads to nephrotoxicity. Inhibition of endocytosis with receptor-associated protein may serve as a clinical approach to reduce or eliminate kidney damage from a potential nephrotoxin. BACKGROUND: Proximal tubules (PTs) are exposed to many exoge...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Mark C., Sandoval, Ruben M., Yadav, Shiv Pratap S., Campos, Silvia B., Rhodes, George J., Phillips, Carrie L., Molitoris, Bruce A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Nephrology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278819/
https://www.ncbi.nlm.nih.gov/pubmed/36848531
http://dx.doi.org/10.34067/KID.0000000000000094
_version_ 1785060550997180416
author Wagner, Mark C.
Sandoval, Ruben M.
Yadav, Shiv Pratap S.
Campos, Silvia B.
Rhodes, George J.
Phillips, Carrie L.
Molitoris, Bruce A.
author_facet Wagner, Mark C.
Sandoval, Ruben M.
Yadav, Shiv Pratap S.
Campos, Silvia B.
Rhodes, George J.
Phillips, Carrie L.
Molitoris, Bruce A.
author_sort Wagner, Mark C.
collection PubMed
description KEY POINTS: Proximal tubule endocytosis of toxins often leads to nephrotoxicity. Inhibition of endocytosis with receptor-associated protein may serve as a clinical approach to reduce or eliminate kidney damage from a potential nephrotoxin. BACKGROUND: Proximal tubules (PTs) are exposed to many exogenous and endogenous nephrotoxins that pass through the glomerular filter. This includes many small molecules, such as aminoglycoside and myeloma light chains. These filtered molecules are rapidly endocytosed by the PTs and lead to nephrotoxicity. METHODS: To investigate whether inhibition of PT uptake of filtered toxins can reduce toxicity, we evaluated the ability of Lrpap1 or receptor-associated protein (RAP) to prevent PT endocytosis. Munich Wistar Frömter rats were used since both glomerular filtration and PT uptake can be visualized and quantified. The injury model chosen was the well-established gentamicin-induced toxicity, which leads to significant reductions in GFR and serum creatinine increases. CKD was induced with a right uninephrectomy and left 40-minute pedicle clamp. Rats had 8 weeks to recover and to stabilize GFR and proteinuria. Multiphoton microscopy was used to evaluate endocytosis in vivo and serum creatinine, and 24-hour creatinine clearances were used to evaluate kidney functional changes. RESULTS: Studies showed that preadministration of RAP significantly inhibited both albumin and dextran endocytosis in outer cortical PTs. Importantly, this inhibition was found to be rapidly reversible with time. RAP was also found to be an excellent inhibitor of PT gentamicin endocytosis. Finally, gentamicin administration for 6 days resulted in significant elevation of serum creatinine in vehicle-treated rats, but not in those receiving daily infusion of RAP before gentamicin. CONCLUSIONS: This study provides a model for the potential use of RAP to prevent, in a reversible manner, PT endocytosis of potential nephrotoxins, thus protecting the kidney from damage.
format Online
Article
Text
id pubmed-10278819
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society of Nephrology
record_format MEDLINE/PubMed
spelling pubmed-102788192023-08-03 Lrpap1 (RAP) Inhibits Proximal Tubule Clathrin Mediated and Clathrin Independent Endocytosis, Ameliorating Renal Aminoglycoside Nephrotoxicity Wagner, Mark C. Sandoval, Ruben M. Yadav, Shiv Pratap S. Campos, Silvia B. Rhodes, George J. Phillips, Carrie L. Molitoris, Bruce A. Kidney360 Original Investigation KEY POINTS: Proximal tubule endocytosis of toxins often leads to nephrotoxicity. Inhibition of endocytosis with receptor-associated protein may serve as a clinical approach to reduce or eliminate kidney damage from a potential nephrotoxin. BACKGROUND: Proximal tubules (PTs) are exposed to many exogenous and endogenous nephrotoxins that pass through the glomerular filter. This includes many small molecules, such as aminoglycoside and myeloma light chains. These filtered molecules are rapidly endocytosed by the PTs and lead to nephrotoxicity. METHODS: To investigate whether inhibition of PT uptake of filtered toxins can reduce toxicity, we evaluated the ability of Lrpap1 or receptor-associated protein (RAP) to prevent PT endocytosis. Munich Wistar Frömter rats were used since both glomerular filtration and PT uptake can be visualized and quantified. The injury model chosen was the well-established gentamicin-induced toxicity, which leads to significant reductions in GFR and serum creatinine increases. CKD was induced with a right uninephrectomy and left 40-minute pedicle clamp. Rats had 8 weeks to recover and to stabilize GFR and proteinuria. Multiphoton microscopy was used to evaluate endocytosis in vivo and serum creatinine, and 24-hour creatinine clearances were used to evaluate kidney functional changes. RESULTS: Studies showed that preadministration of RAP significantly inhibited both albumin and dextran endocytosis in outer cortical PTs. Importantly, this inhibition was found to be rapidly reversible with time. RAP was also found to be an excellent inhibitor of PT gentamicin endocytosis. Finally, gentamicin administration for 6 days resulted in significant elevation of serum creatinine in vehicle-treated rats, but not in those receiving daily infusion of RAP before gentamicin. CONCLUSIONS: This study provides a model for the potential use of RAP to prevent, in a reversible manner, PT endocytosis of potential nephrotoxins, thus protecting the kidney from damage. American Society of Nephrology 2023-02-27 /pmc/articles/PMC10278819/ /pubmed/36848531 http://dx.doi.org/10.34067/KID.0000000000000094 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CC-BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Investigation
Wagner, Mark C.
Sandoval, Ruben M.
Yadav, Shiv Pratap S.
Campos, Silvia B.
Rhodes, George J.
Phillips, Carrie L.
Molitoris, Bruce A.
Lrpap1 (RAP) Inhibits Proximal Tubule Clathrin Mediated and Clathrin Independent Endocytosis, Ameliorating Renal Aminoglycoside Nephrotoxicity
title Lrpap1 (RAP) Inhibits Proximal Tubule Clathrin Mediated and Clathrin Independent Endocytosis, Ameliorating Renal Aminoglycoside Nephrotoxicity
title_full Lrpap1 (RAP) Inhibits Proximal Tubule Clathrin Mediated and Clathrin Independent Endocytosis, Ameliorating Renal Aminoglycoside Nephrotoxicity
title_fullStr Lrpap1 (RAP) Inhibits Proximal Tubule Clathrin Mediated and Clathrin Independent Endocytosis, Ameliorating Renal Aminoglycoside Nephrotoxicity
title_full_unstemmed Lrpap1 (RAP) Inhibits Proximal Tubule Clathrin Mediated and Clathrin Independent Endocytosis, Ameliorating Renal Aminoglycoside Nephrotoxicity
title_short Lrpap1 (RAP) Inhibits Proximal Tubule Clathrin Mediated and Clathrin Independent Endocytosis, Ameliorating Renal Aminoglycoside Nephrotoxicity
title_sort lrpap1 (rap) inhibits proximal tubule clathrin mediated and clathrin independent endocytosis, ameliorating renal aminoglycoside nephrotoxicity
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278819/
https://www.ncbi.nlm.nih.gov/pubmed/36848531
http://dx.doi.org/10.34067/KID.0000000000000094
work_keys_str_mv AT wagnermarkc lrpap1rapinhibitsproximaltubuleclathrinmediatedandclathrinindependentendocytosisamelioratingrenalaminoglycosidenephrotoxicity
AT sandovalrubenm lrpap1rapinhibitsproximaltubuleclathrinmediatedandclathrinindependentendocytosisamelioratingrenalaminoglycosidenephrotoxicity
AT yadavshivprataps lrpap1rapinhibitsproximaltubuleclathrinmediatedandclathrinindependentendocytosisamelioratingrenalaminoglycosidenephrotoxicity
AT campossilviab lrpap1rapinhibitsproximaltubuleclathrinmediatedandclathrinindependentendocytosisamelioratingrenalaminoglycosidenephrotoxicity
AT rhodesgeorgej lrpap1rapinhibitsproximaltubuleclathrinmediatedandclathrinindependentendocytosisamelioratingrenalaminoglycosidenephrotoxicity
AT phillipscarriel lrpap1rapinhibitsproximaltubuleclathrinmediatedandclathrinindependentendocytosisamelioratingrenalaminoglycosidenephrotoxicity
AT molitorisbrucea lrpap1rapinhibitsproximaltubuleclathrinmediatedandclathrinindependentendocytosisamelioratingrenalaminoglycosidenephrotoxicity